Futuximab

DB15262Investigational

Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed
Code names: SYM004

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Futuximab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.